Raltitrexed, a novel folate-based thymidylate synthase inhibitor, for the treatment of acute leukemia: Is this drug active against acute myelogenous leukemia?

Citation
Y. Takemura et al., Raltitrexed, a novel folate-based thymidylate synthase inhibitor, for the treatment of acute leukemia: Is this drug active against acute myelogenous leukemia?, INT J HEMAT, 72(1), 2000, pp. 112-114
Citations number
17
Categorie Soggetti
Hematology
Journal title
INTERNATIONAL JOURNAL OF HEMATOLOGY
ISSN journal
09255710 → ACNP
Volume
72
Issue
1
Year of publication
2000
Pages
112 - 114
Database
ISI
SICI code
0925-5710(200007)72:1<112:RANFTS>2.0.ZU;2-1